Display options
Share it on

Kidney Int Rep. 2016 Nov 08;2(2):228-238. doi: 10.1016/j.ekir.2016.11.001. eCollection 2017 Mar.

Hemodialysis Infection Prevention Protocols Ontario-Shower Technique (HIPPO-ST): A Pilot Randomized Trial.

Kidney international reports

S Daisy Kosa, Amiram Gafni, Andrew A House, JulieAnn Lawrence, Louise Moist, Bharat Nathoo, Paul Tam, Alicia Sarabia, Lehana Thabane, George Wu, Charmaine E Lok

Affiliations

  1. University Health Network-Toronto General Hospital, Toronto, Ontario, Canada.
  2. McMaster University, Hamilton, Ontario, Canada.
  3. London Health Sciences Centre, London, Ontario, Canada.
  4. Mackenzie Health Hospital, Vaughan, Ontario, Canada.
  5. The Scarborough Hospital, Scarborough, Ontario, Canada.
  6. Credit Valley Hospital, Mississauga, Ontario, Canada.

PMID: 29142959 PMCID: PMC5678668 DOI: 10.1016/j.ekir.2016.11.001

Abstract

INTRODUCTION: We developed the Hemodialysis Infection Prevention Protocols Ontario-Shower Technique (HIPPO-ST) to permit hemodialysis (HD) patients with central venous catheters (catheters) to shower without additional infection risk. Our primary objective was to determine the feasibility of conducting a parallel randomized controlled trial (RCT) to evaluate the impact of HIPPO-ST on catheter-related bacteremia (CRB) in adult HD patients.

METHODS: Adult HD patients using catheters were recruited from 11 HD units. Patients were randomized to receive HIPPO-ST or standard care and were followed up for 6 months. Only CRB-outcome assessors were blinded. For the study to be considered feasible, 4 of 5 feasibility outcomes, each with its own statistical threshold for success, must have been achieved.

RESULTS: A total of 68 patients were randomized (33 HIPPO-ST and 35 control) and were followed up to 6 months. Of 5 measures of feasibility, 4 were achieved: (1) accurate CRB rate documented (threshold: κ level >0.80); (2) 97.8% (279/285) of satellite HD patients with catheters were screened (threshold: >95%); (3) 88% (23/26) in the HIPPO-ST arm were successfully educated by 6 months (threshold: >80%); and (4) 0% (0/29) patients in the control arm were "contaminated," that is, using HIPPO-ST (threshold: <5%). However, only 44.2% (72/163) of eligible patients consented to participate (threshold: >80%). The rate of CRB was similarly low in HIPPO-ST and control groups (0.68 vs. 0.88/1000 catheter days).

DISCUSSION: This HIPPO-ST pilot study demonstrated the feasibility of the larger HIPPO-ST study, especially given the high levels of education success with the HIPPO-ST arm and the low levels of contamination in the control arm.

Keywords: catheter; hemodialysis; pilot study; randomized controlled trial; vascular access

References

  1. Clin J Am Soc Nephrol. 2007 Jan;2(1):89-99 - PubMed
  2. Qual Life Res. 2007 May;16(4):545-57 - PubMed
  3. J Vasc Surg. 2005 Sep;42(3):585-6 - PubMed
  4. Adv Chronic Kidney Dis. 2006 Jul;13(3):225-44 - PubMed
  5. J Grad Med Educ. 2013 Dec;5(4):541-2 - PubMed
  6. BMC Med Res Methodol. 2010 Jan 06;10:1 - PubMed
  7. Nephrol Dial Transplant. 2003 Jun;18(6):1174-80 - PubMed
  8. Nephrol Dial Transplant. 2006 Apr;21(4):1024-31 - PubMed
  9. Clin Infect Dis. 2009 Dec 1;49(11):1770-1; author reply 1771-2 - PubMed
  10. Nephrol Dial Transplant. 2007 Feb;22(2):477-83 - PubMed
  11. J Vasc Surg. 1999 Oct;30(4):727-33 - PubMed
  12. Infect Control Hosp Epidemiol. 2005 Feb;26(2):175-83 - PubMed
  13. Nephrol Nurs J. 2014 Jan-Feb;41(1):53-64; 72; quiz 65 - PubMed
  14. Infect Control Hosp Epidemiol. 2005 Jun;26(6):534-9 - PubMed
  15. J Am Soc Nephrol. 2003 Jan;14(1):169-79 - PubMed
  16. Semin Dial. 2013 Jul-Aug;26(4):482-93 - PubMed
  17. J Vasc Access. 2011 Apr-Jun;12(2):120-6 - PubMed
  18. Can Commun Dis Rep. 1997 Dec;23 Suppl 8:i-iii, 1-32, i-iv, 1-16 - PubMed
  19. J Am Soc Nephrol. 2006 Mar;17(3 Suppl 1):S1-27 - PubMed
  20. Semin Dial. 2014 Jan-Feb;27(1):72-7 - PubMed
  21. Kidney Int. 2005 Jun;67(6):2462-9 - PubMed
  22. Int J Nephrol. 2012;2012:170857 - PubMed
  23. Kidney Int. 2011 Mar;79(6):587-98 - PubMed
  24. Kidney Int. 2000 May;57(5):2151-5 - PubMed
  25. Am J Med Sci. 2002 Nov;324(5):254-60 - PubMed
  26. J Vasc Access. 2015 May-Jun;16(3):200-5 - PubMed
  27. Kidney Int. 2005 Jul;68(1):311-8 - PubMed
  28. Am J Kidney Dis. 2005 Aug;46(2):301-8 - PubMed
  29. J Vasc Access. 2008 Apr-Jun;9(2):122-8 - PubMed
  30. Infect Control Hosp Epidemiol. 2007 May;28(5):606-9 - PubMed
  31. Nurs Res. 1986 Nov-Dec;35(6):382-5 - PubMed
  32. Ann Intern Med. 2010 Jun 1;152(11):726-32 - PubMed
  33. Am J Kidney Dis. 2011 Mar;57(3):432-41 - PubMed
  34. Kidney Int. 1998 Nov;54(5):1684-9 - PubMed
  35. Semin Dial. 2006 Sep-Oct;19(5):381-90 - PubMed
  36. Am J Kidney Dis. 2002 Sep;40(3):611-22 - PubMed
  37. Semin Dial. 2008 Nov-Dec;21(6):528-38 - PubMed
  38. Nephrol Nurs J. 2014 Jan-Feb;41(1):67-72; quiz 73 - PubMed

Publication Types